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Abstract
Background & Aims—The loss of parietal cells from the fundic mucosa leads to the emergence
of metaplastic lineages associated with an increased susceptibility to neoplastic transformation. Both
intestinal metaplasia (IM) and spasmolytic polypeptide (TFF2/SP) expressing metaplasia (SPEM)
have been identified in human stomach, but only SPEM is present in most mouse models of gastric
metaplasia. We previously determined that loss of amphiregulin (AR) promotes SPEM induced by
acute oxyntic atrophy. We have now examined whether SPEM in the AR−/− mouse predisposes the
stomach to gastric neoplasia.
Methods—Gross pathology of 18-month-old wild-type, AR−/−, and TGF-α −/− mice were
examined. Ki-67, β-catenin, Pdx-1, TFF3, and TFF2/SP expression was analyzed by
immunohistochemistry. Metaplastic gastric mucosa was analyzed by dual immunostaining for TFF2/
SP with MUC2 or TFF3.
Results—By 18 months of age, more than 70% of AR−/− mice developed SPEM while 42% showed
goblet cell IM labeled with MUC2, TFF3, and Pdx-1. A total of 28% had invasive gastric lesions in
the fundus. No antral abnormalities were observed in AR−/− mice. Metaplastic cell lineages in
AR−/− mice showed increases in cell proliferation and cytosolic β-catenin expression. Dual staining
for TFF2/SP with MUC2 or TFF3 showed glands containing both SPEM and IM with intervening
cells expressing both TFF2/SP and MUC2 or TFF2/SP and TFF3.
Conclusions—AR−/− mice develop SPEM, which gives rise to goblet cell IM and invasive fundic
dysplastic lesions. The AR−/− mouse represents the first mouse model for spontaneous development
of fundic SPEM with progression to IM.
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The gastric epithelium is geographically heterogeneous, containing functionally distinct
pyloric and fundic mucosal lineages. The normal fundic mucosa is assembled from a diverse
group of cell lineages responsible for luminal secretion of mucins, intrinsic factor, acid, and
pepsinogen. While pyloric mucosal lineages, similar to intestinal mucosal units, arise from
basally located proliferative zones, lineages in the fundic mucosa arise from a progenitor zone
located in the luminal third of the glands.1 Surface cells migrate toward the lumen. A small
number of differentiating parietal cells migrate toward the lumen in the mouse, whereas most
parietal cells progress toward the base of the gland.2 In humans, the loss of parietal cells is a
prerequisite step for the development of intestinal-type gastric cancer.3 Active chronic gastritis,
most often caused by Helicobacter pylori infection, progresses to multifocal atrophic gastritis
with loss of parietal cells and chief cells and the appearance of metaplastic lineages that are
predisposed to neoplastic transformation. Thus, oxyntic atrophy, the loss of parietal cells,
represents the critical alteration of the gastric mucosal most associated with gastric
preneoplasia.
The loss of parietal cells leads to the development of 2 identifiable metaplasias associated with
gastric cancer: intestinal metaplasia (IM) and spasmolytic polypeptide-expressing metaplasia
(SPEM). Goblet cell IM has received the most consideration as the most prominent candidate
for origination of gastric cancer.4,5 The presence of cells with goblet cell morphology in the
stomach represents a clear example of a metaplastic process with intestinal phenotype cells
expressing MUC2 and trefoil family factor (TFF) 3.6 – 8 A second gastric metaplasia,
designated SPEM,9,10 is characterized by the presence of TFF2 (or spasmolytic polypeptide)
immunoreactive cells in the base of gastric fundus, showing oxyntic atrophy with morphologic
characteristics similar to those of deep antral gland cells or Brunner’s gland cells.8 Thus, while
IM expresses MUC2 and TFF3, MUC6 and TFF2 are useful markers for SPEM.11,12 Both of
these metaplasias have been associated with the development of gastric cancer in humans,5,
13 but there remains a lack of direct evidence linking specific gastric metaplasias with the
neoplastic process. In addition, the relationship between SPEM and IM remains obscure.
Epidermal growth factor (EGF) receptor ligands are critical regulators of epithelial cell
differentiation. Parietal cells secrete a number of EGF receptor ligands, including transforming
growth factor (TGF)-α, amphiregulin (AR), and heparin-binding EGF.14 –17 In addition,
surface mucous cells and enterochromaffin-like cells are also a source of at least TGF-α.18
Previous studies have documented the influence of EGF receptor ligands on the differentiation
of gastric cell lineages. While loss of TGF-α expression has little effect on gastric lineages,
overexpression of TGF-α in surface mucous cells leads to foveolar hyperplasia and loss of
glandular lineages and is responsible for the pathological phenotype of Ménétrier’s disease in
humans.19 Previous investigations have also shown that AR levels are elevated in the stomachs
of insulin-gastrin mice infected with Helicobacter felis20 or following hypoxia/reoxygenation
in gastric cells in culture.21 Recently, we elucidated evidence for a definitive role for parietal
cell– derived peptides in regulating SPEM lineage development.22 We showed in 8-week-old
mice that, while TGF-α– deficient mice developed SPEM along a similar time course as wild-
type (WT) mice, AR-deficient mice developed SPEM at an accelerated rate in response to acute
oxyntic atrophy. In addition to a more accelerated development of SPEM, AR-deficient mice
also showed a greater expansion of SPEM. We have now sought to determine whether SPEM
in the AR-deficient mouse predisposes the stomach to gastric neoplasia. The current results
show that AR-null mice develop oxyntic atrophy and SPEM spontaneously by 10 months of
age. By 18 months of age, SPEM in turn gives rise to goblet cell IM and invasive fundic mucosal
lesions. Thus, the AR-null mouse model represents the first mouse model for spontaneous
development of fundic SPEM with progression to IM and neoplasia.
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Materials and Methods
Animals
The generation of AR-null mice, heterozygous AR+/− mice, and TGF-α–null mice has been
described previously in detail.22 Mice were maintained on the C57BL/6 background under
specific pathogen-free conditions in individual, sterile microisolator cages in non-barrier
mouse rooms. C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME).
During the experiments, the mice were maintained with regular mouse chow and water ad
libitum in a temperature-controlled room under a 12-hour light/dark cycle. The care,
maintenance, and treatment of animals in these studies followed protocols approved by the
Institutional Animal Care and Use Committee of Vanderbilt University.
Study Design
Mice were divided into 4 groups: AR deficient (AR−/−, n = 17), AR heterozygous (AR+/−, n =
14), TGF-α deficient (TGF-α−/−, n = 21), and WT (n = 16). Each group of mice was examined
at 10 months (AR−/−, n = 10; AR+/−, n = 6; TGF-α −/−, n = 13; WT, n = 10) and 18 months
(AR−/−, n = 7; AR+/−, n = 8; TGF-α −/−, n = 8; WT, n = 6) of age without any treatment.
Immediately after the mice were killed, their stomachs were opened along the greater curvature.
One half of the glandular stomach was fixed for histologic examination, and the other half was
homogenized in sterile phosphate-buffered saline, plated on selective blood agar plates, and
incubated for 5–7 days for Helicobacter sp. culture to test for infection. The excised stomachs
were fixed in neutral buffered 10% formalin and cut into approximately 6 strips, processed by
standard methods, embedded in paraffin, and sectioned at 5 μm.
Details of methods for staining tissue sections and serum and tissue cytokine expression assays
are described in the Supplementary Methods.
Results
Spontaneous Tumors Develop in the Gastric Fundus, But Not in the Antrum, of AR−/− Mice
We recently found that AR deficiency caused more extensive induction of SPEM in response
to acute oxyntic atrophy, suggesting differential roles of respective EGF ligand in cell lineage
differentiation in the gastric unit.22 To evaluate the long-term effects of AR deficiency, we
systemically evaluated the stomachs of AR−/− mice at 10 and 18 months of age compared with
age-matched WT mice. To examine the long-term effects of other EGR ligands produced by
parietal cells, TGF-α – deficient mice were also evaluated at 10 and 18 months of age.
Examination of AR−/− mouse stomachs at 10 months of age revealed the presence of
macroscopically visible tumors in 3 out of the 10 mice examined (Figure 1A), while stomachs
from all AR+/−, TGF-α −/−, and WT mice exhibited normal gastric morphology. All 3 of the
tumors observed were in the fundic region of the AR−/− mouse stomach. Notably, in 18-month-
old AR−/− mice, we observed large macroscopically visible tumors in 5 (71%) of the 7 mice
examined (Figure 1B), while stomachs from all AR+/−, TGF-α −/−, and WT mice exhibited
normal gastric morphology. All 5 of the tumors observed were in the fundic region of the
AR−/− mouse stomach. In contrast to the fundic area, the antral mucosa in AR−/− mice
maintained a normal appearance even at the demarcation between the fundus and antrum
(Figure 1B). Histologic examination of the stomach showed a vastly expanded fundic mucosa
in the 18-month-old AR−/− mice. However, histologic examination of the antrum revealed a
normal mucosal morphology (Figure 1C).
Fundic Mucosa in AR−/− Mice Was Expanded by Development of SPEM
To evaluate further the characteristics of the expanded fundic area in AR−/− mice, we examined
the metaplastic and hyperplastic response in the fundic mucosa of these mice. The fundic
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mucosa in AR−/− mice demonstrated marked expansion of metaplastic glands.
Morphologically, the expanded fundic mucosa in AR−/− mice showed extensive replacement
of the oxyntic glands by elongated columnar epithelial cells, often with mixed mucin expression
(Figure 2C and E). The metaplastic glands of the fundic mucosa were hyperplastic and
contained Alcian blue–positive glands abnormally invading into the muscularis mucosa with
prominent cystic structures within the submucosa of the gastric wall (Figure 2C and D). To
identify parietal cells, we immunostained AR−/− stomach sections with antibodies against the
α-subunit of the H+/K+–adenosine triphosphatase. In the expanded fundic region, the number
of parietal cells was markedly decreased. The few remaining parietal cells appeared atrophic
and were scattered through the glands (Figure 2E). To identify columnar metaplastic cells in
the AR−/− mouse fundic mucosa, we immunostained gastric tissue with antibodies against
TFF2/SP. The elongated fundic metaplastic mucosal glands were dominated by intensely
stained TFF2/SP-expressing cells (Figure 2F). This staining pattern was similar to that
previously described for TFF2/SP staining in SPEM cells.22,23
Characteristics of Invasive Fundic Mucosal Lesions in AR−/− Mice
To investigate the characteristics of the submucosal invasive fundic lesions, we immunostained
gastric tissue for markers associated with neoplastic transformation with antibodies against
Ki-67 and β-catenin. TFF2/SP-positive metaplastic glands were present in the invasive fundic
gland area in AR−/− mice (Figure 3A). In cells at the bases of the fundic glands, including
cystically dilated glands, we detected proliferating cells by Ki-67 staining (Figure 3B). To
define the possible activation of the Wnt signaling pathway in the region of submucosal gland
invasion, we determined the subcellular localization of β-catenin by immunohistochemical
staining. Membrane-localized β-catenin was detected in cells within the gland mucosal area
(M), but we observed numerous cells containing cytoplasmic staining with some cells also
showing nuclear β-catenin in invading submucosal glands, oriented perpendicular to the
muscularis mucosa (MM) (Figure 3C).
To analyze the characteristics of the fundic area in AR−/− mice, morphologic changes were
examined at different ages by a pathologist (Table 1). Figure 4 summarizes representative
criteria for the pathologic findings present in the AR−/− mice showing dysplasia, fundic
hyperplasia, SPEM, and persistent submucosal inflammatory cell infiltration. Dysplasia was
defined as dissociation of normal mucosal architecture and the presence of epithelial cells that
display hyperchromatic nuclei, pleomorphic atypical shape, and a disorganized appearance
(Figure 4A). In another area of fundic tumor, we observed expanding dysplasia invading into
surrounding SPEM (Figure 4B). Fundic hyperplasia was characterized by a polypoid growth
pattern of foveolar cells and irregular small compact glandular growths composed of cells with
hyperchromatic nuclei within the mucosa (Figure 4C). Interestingly, mice with fundic
hyperplasia did not show evidence for SPEM.
In AR−/− mice, we observed that regions of the mucosa with severe SPEM were generally
associated with submucosal infiltration of inflammatory cells (Table 1). The inflammatory
cells, chiefly polymorphonuclear leukocytes, were locally infiltrated in the submucosa only,
and there were no inflammatory infiltrates in the mucosa (Figure 4D). Given the pattern of
submucosal infiltrates, we sought to characterize the nature of the inflammatory response by
comparing both serum cytokine levels and tissue cytokine messenger RNA (mRNA)
expression in 10-month-old WT mice as well as both TGF-α and AR knockout mice. Figure 5
shows that, compared with WT mice, both TGF-α– deficient and AR-deficient mice showed
significant increases in the serum levels of the 5 cytokines assayed: interleukin (IL)-2, IL-4,
IL-5, tumor necrosis factor (TNF)-α, and interferon gamma. However, levels of IL-5, a Th2
cytokine, were elevated to a significantly higher level in AR−/− mice compared with TGF-
α −/− mice (Figure 5).
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To examine cytokine levels more directly in the gastric tissues, we also assessed mRNA levels
for these cytokines in the stomachs of WT, TGF-α– deficient, and AR-deficient mice. Figure
6 shows that gastric tissue mRNA levels for the 5 cytokines were not significantly different in
TGF-α knockout mice compared with WT controls. However, mRNA for IL-2, IL-4, IL-5, and
TNF-α were all elevated in AR knockout mice compared with both WT and TGF-α– deficient
mice. These results suggest that AR knockout mice demonstrate elevations in both Th1 and
Th2 cytokine production in the gastric mucosa.
SPEM Progressed Into IM in AR-Deficient Mice
In contrast to humans, mice rarely develop goblet cell IM in response to loss of parietal cells
in the fundus and only manifest SPEM lineages in the atrophic stomach.9 While we have
described SPEM associated with a number of animal models of oxyntic atrophy,9,23–25 none
of these animals developed goblet cell IM in fundus. Nevertheless, in AR−/− mice, we observed
progression of SPEM to goblet cell IM. Alcian blue–staining goblet cells were present in the
fundic mucosa of 18 month-old AR−/− mice in proximity to regions of gastritis cystica profunda
(Figure 7A). To confirm the identification of goblet cell IM, we immunostained sections of
fundus with antibodies against TFF3. In the mucosal glands of 18-month-old AR−/− mice,
TFF3-positive goblet cells were observed (Figure 7A). We have previously noted that in
humans IM expresses the duodenal transcription factor Pdx-1, while Pdx-1 is not expressed in
SPEM.26 We therefore examined Pdx-1 staining in the fundus of 18-month-old AR−/− mice.
While Pdx-1 was not expressed in the fundus of WT or TGF-α– deficient mice (data not shown),
IM regions in AR knockout mice showed cells with prominent nuclear expression of Pdx-1
(Figure 7B). Of note, however, SPEM in the surrounding regions of the metaplastic mucosa
did not demonstrate Pdx-1 expression. These results indicate that the AR-deficient mice are
recapitulating many of the aspects of human gastric IM. Interestingly, we did not detect Cdx-2
immunostaining in either the duodenum or areas of IM in the fundus (data not shown).
Because goblet cell IM in AR−/− mice always developed in the setting of the mucosa with
marked SPEM, we hypothesized that metaplastic SPEM cells may progress into IM goblet
cells. To investigate the relationship of goblet cell IM to SPEM, we used dual
immunofluorescence labeling to examine staining for TFF2/SP with TFF3 or TFF2/SP with
MUC2. Dual staining of TFF2/SP and TFF3 showed the presence of glands containing both
TFF2/SP-positive SPEM cells and TFF3-positive IM (Figure 7C, upper panel). In many
instances, cells within both branching glandular structures as well as within cystic glands
showed dual staining for both TFF2/SP and TFF3. Similar results were observed with dual
staining for TFF2/SP and MUC2. In particular, in invasive areas of gastritis cystica profunda,
cells staining for both TFF2/SP and MUC2 were widely distributed in the dilated cystic glands
(Figure 7C, lower panel). These results suggested that SPEM glands may give rise to IM.
Discussion
Gastric adenocarcinoma can be categorized by 2 histologic characteristics. The diffuse type is
remarkable for its poorly differentiated phenotype in which the glandular architecture is
completely lost. Recent investigations in cohorts of familial diffuse gastric cancer as well as
in some patients with sporadic diffuse cancer have shown a causal association of carcinogenesis
with mutations in cadherins and catenins.27–29 Mutations in E-cadherin or β-catenin lead to a
loss of polarity and promote dysplastic transition.30 Intestinal-type tumors, which make up the
majority of sporadic tumors worldwide, appear to evolve through a series of discrete steps
originally described by Correa.4 Intestinal-type cancers are strongly associated with oxyntic
atrophy3 as well as a number of metaplastic lineages.31–33 The original description of the
metaplasia-to-cancer scenario in gastric cancer focused on the role of goblet cell IM as a
putative precursor to gastric neoplasia. It is now clear that a second metaplastic lesion, SPEM,
NAM et al. Page 5
Gastroenterology. Author manuscript; available in PMC 2010 March 24.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
is also associated with gastric cancer. Although SPEM accompanied by gastric atrophy is
associated more commonly with gastric cancer than IM, the exact relationship between the 2
metaplasias and intestinal-type cancer remains unclear.
The roles of specific metaplasias in gastric cancer have not been clarified by studies using
mouse models of Helicobacter spp infection, where IM was not observed but SPEM appeared
as a prominent precursor to gastric neoplasia.9 Indeed, with the exception of forced ectopic in
the stomach expression of the master regulating transcription factor Cdx2,34 none of the mouse
models of gastric atrophy and metaplasia have developed goblet cell IM. It is notable, however,
that mice with forced expression of Cdx2 in the stomach do develop goblet cells in the gastric
mucosa and progress to dysplastic lesions.35 In contrast to the mouse, H pylori infection in
Mongolian gerbils does produce goblet cell IM. Importantly, however, recent investigations
have documented that SPEM develops in infected gerbils long before IM and that IM develops
in the setting of a fundic mucosa already showing SPEM as the predominant metaplasia.36 In
the present studies, AR−/− mice developed oxyntic atrophy and SPEM by 10 months of age,
which was followed by goblet cell IM arising in the context of SPEM. Importantly, we observed
that goblet cells were present in the luminal region of glands that also contained SPEM at their
bases. Furthermore, at the interface of the SPEM and IM regions, we observed cells that dually
expressed either TFF2 and MUC2 or TFF2 and TFF3. Similar dual lineage glands were also
observed in H pylori–infected Monogolian gerbils.36 These results suggest that IM can arise
from foci of TFF2-expressing metaplastic cells within SPEM glands. This type of metaplastic
lineage conversion has also been observed in the ulcer-associated cell lineage described by
Wright et al in association with Crohn’s disease in the colon.37,38 The results here indicate that
a dynamic process of metaplasia may give rise first to SPEM in the setting of oxyntic atrophy
followed by evolution of IM.
We have previously reported that AR-deficient mice develop SPEM more quickly and to a
greater extent following induction of acute oxyntic atrophy with administration of the parietal
cell protonophore DMP-777.22 Nevertheless, while those original studies were performed in
8-week-old animals, the present investigations indicate that AR-null mice progress to oxyntic
atrophy and SPEM after 10 months of age without drug treatment. Because of the prominent
changes in these mice, we examined the stomachs for the presence of Helicobacter spp
infection but were unable to identify any Helicobacter present in the AR-deficient mice. Thus,
while we cannot rule out other possible inciting infections,11,39 it appears that the AR-null
mice can progress to oxyntic atrophy and metaplastic lesions spontaneously. Such spontaneous
progression to oxyntic atrophy and metaplasia has previously been observed in insulin-gastrin
transgenic mice,40 although those mice developed SPEM but not IM. One possible explanation
for the development of metaplasia and neoplasia in AR knockout mice may relate to the
accompanying chronic inflammatory response. While Helicobacter felis–infected mice
develop SPEM in the setting of marked intramucosal and submucosal infiltrates, we observed
only moderate submucosal infiltrates in AR−/− mice. Importantly, however, these submucosal
infiltrates were often associated with regions of SPEM in the mucosa. While Helicobacter
infection has generally been associated with a Th1 immune response,41,42 we observed a mixed
picture of elevations of both Th1 and Th2 cytokine expression in the gastric tissue of AR−/−
mice compared with both age-matched WT and TGF-α −/− mice. Additionally, the submucosal
infiltrates were comprised predominantly of polymorphonuclear leukocytes. Based on recent
published data, AR secreted by hematopoietic (probably Th2) cells significantly enhances the
expulsion of intestinal parasites.43 Comparing AR-deficient and WT C57BL/6 mice after
infection with Trichuris muris, worm clearance was significantly delayed in AR-deficient mice.
In a reconstitution experiment, AR-expressing bone marrow cells significantly restored
parasite clearance in AR-deficient mice. The exact cause for inciting a chronic submucosal
inflammatory response in AR-deficient mice is not clear but could be related to a response to
chronic injury or autoimmunity.
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As noted in our previous studies,22 the phenotypes for AR-deficient and TGF-α–null mice were
markedly different. TGF-α–null mice did not develop any significant mucosal lesions in the
fundus, in comparison with the prominent changes in the AR-deficient mice. These results
indicate that, while both AR and TGF-α exert their influences on mucosal cells through the
EGF receptor, the actions of these peptides on cell physiology must be distinct. Parietal cells
are known to secrete several EGF receptor ligands, including TGF-α, AR, and heparin-binding
EGF.14 –17 Other gastric mucosal cells can secrete at least TGF-α and EGF. Recent
investigations have suggested that EGF receptor ligands may compete for occupancy of the
EGF receptor.44,45 Thus, alterations in the levels of certain EGF receptor ligands may lead to
increased signaling by others. The net effect of the loss of AR may therefore reflect a cascade
of signaling through EGF receptor occupancy by other receptor ligands. Over time, these
changes might be expected to regulate both inflammatory response and long-term lineage
differentiation.
In conclusion, these studies show that SPEM is an early metaplastic change in the fundus of
the stomach in the setting of AR deficency. We observed both SPEM IM as well as evidence
of early invasive neoplasia in AR-deficient mice. IM evolved in the setting of precedent SPEM,
suggesting that IM arises from SPEM. These findings in AR-null mice represent the first mouse
model of both SPEM and IM induction associated with eventual neoplasia. Collectively, these
results indicate that atrophic gastritis leads to the generation of a dynamic scenario of
metaplastic changes that predispose to the development of gastric neoplasia.
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Figure 1.
AR-deficient mice develop gross fundic tumors. Gross appearance of (A) a 10-month-old AR-
deficient mouse stomach and (B) an 18-month-old AR-deficient mouse stomach. (A) The 10-
month-old mice showed visible nodules arising in the fundic area, while (B) 18-month-old
mice showed grossly visible tumors in the fundic area. (C) H&E staining of the stomach of an
18-month-old AR-deficient mouse. Note the vastly expanded fundic mucosa (Fundus) in
contrast to the normal antral (Antrum) morphology in the histologic sections of the stomach.
Bar = 1 mm.
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Figure 2.
Characterization of expanded fundic glands in 18-month-old AR-deficient mice. (A and B)
Histologic sections of normal fundus stained with either (A) H&E or (B) periodic acid–Schiff/
Alcian blue. (C–F) Histologic sections of fundus from an 18-month-old AR-deficient mouse
stained with (C) H&E, (D) periodic acid–Schiff/Alcian blue, (E) anti–H/K-adenosine
triphosphatase, or (F) anti-TFF2. AR-deficient mice showed extensive replacement of the
normal gland cell lineages by columnar mucous cells that were both periodic acid–Schiff and
Alcian blue positive. Note the invasion of the metaplastic glands into muscle layer with
cystically dilated glands (arrows in C). (E and F) Staining in serial sections of fundic gland
region outlined in the white box in C showed severe loss of parietal cells (E) and replacement
of virtually the entire mucosal gland length with intensely staining TFF2/SP-expressing cells.
Bar = 100 μm.
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Figure 3.
Characteristics of invasive fundic glands in 18-month-old AR-deficient mice. To characterize
the invasive regions of the metaplastic mucosa, sections were stained for (A) TFF2/SP, (B)
Ki-67, and (C) β-catenin. (A) TFF2/SP-positive glands also were present in the invasive fundic
gland area. (B) Note the Ki-67–positive cells in the invasive area, especially in cystic lesions.
(C) Membrane localized β-catenin was detected in the glands within the mucosal area (M), but
note the number of cells containing cytoplasmic β-catenin in submucosal (SM) invasive glands
deep to the muscularis mucosa (MM). Bar = 50 μm.
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Figure 4.
Histopathologic analysis of representative fundic lesions in AR-deficient mice. Sections of
fundic stomach from 18-month-old AR-deficient mice were stained with H&E and examined
for histopathologic findings. (A and B) Invasive areas with histologic features of dysplasia.
(B) Note the expanding dysplasia invading into the adjacent SPEM regions (arrows). (C)
Fundic hyperplasia. Note the polypoid growth pattern of foveolar cells. Parietal cells around
the polyp were normal. (D) Submucosal infiltration of inflammatory cells. Note the
inflammatory cells were locally infiltrated in the submucosa only. There were no inflammatory
infiltrates observed in the mucosa. Bar = 50 μm.
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Figure 5.
Serum levels of cytokines determined in AR- and TGF-α–deficient mice. Serum levels of IL-2,
TNF-α, interferon gamma (IFN-γ), IL-5, and IL-4 were determined in 10-month-old WT, AR-
deficient, and TGF-α–deficient mice. Both TGF-α and AR knockout mice showed significant
elevations in all 5 cytokines compared with WT mice (*P < .01). In addition, levels of IL-5
were significantly elevated in AR−/− mice compared with TGF-α −/− (#P < .01).
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Figure 6.
Cytokine mRNA expression levels in gastric tissue from AR-and TGF-α–deficient mice. Total
RNA was prepared from gastric tissue of 10-month-old WT, AR-deficient, and TGF-α–
deficient mice. Cyto-kine mRNA expression was determined by quantitative reverse-
transcription polymerase chain reaction for IL-2, IL-4, IL-5, TNF-α, and interferon gamma
(INF-γ). No significant differences were observed between WT and TGF-α–deficient mice.
However, significant elevations in IL-2, IL-4, IL-5, and TNF-α expression were observed in
the gastric mucosa of AR-deficient mice compared with WT and TGF-α–deficient mice (*P
< .05, **P < .01).
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Figure 7.
SPEM progresses to intestinal metaplasia in 18-month-old AR-deficient mice. (A) To identify
goblet cell IM, sections of fundic stomach from 18 month-old AR-deficient mice were stained
for H&E, Alcian blue, and TFF3 immunohistochemistry in adjacent sections. The stains show
Alcian blue and TFF3-positive goblet cells within the mucosa. (B) To investigate the
characteristics of goblet cell IM in stomach, sections from AR-deficient mice fundic mucosa
were immunostained for the duodenal transcription factor Pdx-1. While Pdx-1 was not
expressed in the SPEM regions, IM regions showed cells with prominent nuclear expression
of Pdx-1. Note that no expression of Pdx-1 was observed in SPEM (S) in the surrounding
regions of the IM (I). (C) To investigate IM development in the setting of SPEM, fundic sections
from 18-month-old AR-deficient mice were dual stained for immunofluorescence labeling of
TFF2/SP with TFF3 or TFF2/SP with MUC2. Note the TFF3-positive goblet cells appeared
within TFF2/SP-positive glands (upper panels). In the invasive area (white dashed line
indicates the position of the muscularis mucosa), cells staining for both TFF2/SP and MUC2
were observed in cystically dilated glands (lower panels). Panels at the far right show higher-
magnification views of merged fluorescence images showing cells with dual labeling for either
TFF2 with TFF3 or TFF2 with MUC2. Bar = 25 μm.
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